
Finland · research
Rappta Therapeutics is a lead-optimization stage biopharmaceutical company.
PrivateFor profit
Set against 3,254 research companies worldwide. The ring marks the typical peer.
Across all 5.9M companies: larger than 33% of those with a size listed; older than 40% of those with a founding year.
BiopharmaBiotechnologyLife Science
What the source datasets report. We have not watched these rounds ourselves.
$9.0M
raised in total, currency not stated across 1 round
Last raised Oct 2020, 6 years ago
Who started it and how it trades.
Everything the source datasets list about Rappta Therapeutics, field by field. Contact details are held but never shown.
The company7 fields
Where3 fields
Size and reach1 field
Funding, as listed7 fields
About this record2 fields
Growth, as the source summarises it
Rappta Therapeutics may be growing as evidenced by the company's involvement in various capacities within the biopharmaceutical industry. The company is mentioned in the context of stock and other ownership interests, which suggests that it is recognized in the investment community and may have a shareholder base that is interested in its growth potential. Additionally, the mention of Rappta Therapeutics alongside other companies in a scientific advisory or consultancy capacity indicates that it is engaged in collaborative efforts or providing expertise in its field, which can be indicative of operational growth and industry recognition. Furthermore, the company's inclusion in a list with other notable entities such as Alligator, Silverback, and Gilead reflects its presence and potential activity within the biopharma and biotechnology sectors.
Every research company, filtered by size, age and reach, ready to export with emails on Pro.